Antitoxins

Antitoxins

Biodefense Headlines – 31 March 2025

Biosecurity March 31, 2025

This week’s topics include restructuring of ASPR, anti-vaccine leadership at NIH, the UK’s new pathogen priority research targets list, and data on a post-exposure treatment for filoviruses. FEATURED Trump Administration…

Happening This Week: ASM Biothreats

BARDA BAA 2018: Pandemic Influenza, Infectious Diseases, CBRN Countermeasures

Medical Countermeasure Nonclinical Studies Network Contract Awards

HHS Releases 2016 PHEMCE Strategy and Implementation Plan

Health Canada Approves NDS for Botulinum Neurotoxin Countermeasure

NIH Awards 19M for Development of Nerve Agent Medical Countermeasures

BARDA Industry Day 2016

Webinar Available on Chemical Threat Countermeasure Funding

Improving the Nation’s Medical Countermeasure Stockpile

Battelle Fills Central Role in Military’s Medical Countermeasure Enterprise

Pharma Manufacturing and Pandemic Preparedness

FDA Approves New Injection for Inhalational Anthrax

Permeability Simulation Speeds Development of Nerve Agent Countermeasures

Rapid Medical Countermeasure Response to Infectious Diseases

DoD Seeks Participants for National Chemical and Biological Defense Consortium

PHEMCE Medical Countermeasure Stakeholders Workshop

DoD CBRN Medical Countermeasure Consortium

HHS Adds New Anthrax Countermeasures to Stockpile

CounterACT Grants for Chemical Countermeasures Research

Multicenter Program for Botulinum Neurotoxin Countermeasures

Biodefense Headlines – 31 March 2025